Date and Time
Wednesday April 24th | 19:00 - 20:00
Overview
With the news that two dry AMD treatments have been approved in the US and with trials of the treatments now underway in the UK, many people are understandably keen to learn more about what the treatments are, how likely they are to be approved in the UK and if so who will receive them. Mr James Neffendorf will provide an update on this as well as shedding light on any new wet AMD treatments.
As well as this, we will hold a live Q&A with Mr Neffendorf and OcuPlan will spend a couple of minutes talking about their new upcoming AMD virtual service.
If you'd like to attend, please register by completing the form below. We will provide the webinar dial-in details closer to the time.